A synthetic peptide for use as a blocking control in assays to test for specificity of DLAT antibody, Alternative Names: DLAT control peptide, DLAT antibody Blocking Peptide, Anti-DLAT Blocking Peptide, Dihydrolipoamide S-Acetyltransferase Blocking Peptide, DLTA Blocking Peptide, PDC-E2 Blocking Peptide, PDCE2 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
DLAT
(Dihydrolipoyl Transacetylase (DLAT))
Hintergrund
DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.